Published: 7 May 2020
Author(s): Adam H Dyer, Claire Murphy, Brian Lawlor, Sean P Kennelly, NILVAD Study Group⋆⋆
Section: Letter to the Editor

Proton-Pump Inhibitors (PPIs) are commonly prescribed medications indicated for the treatment of various acid-related disorders including duodenal/gastric ulcers, erosive oesophagitis and Helicobacter Pylori eradication1,2. PPIs are frequently used without appropriate indication in older adults and are associated with numerous adverse effects including bone loss, fractures, community acquired pneumonia and chronic kidney disease1,2. Strikingly, several studies have also reported a greater risk of dementia in those receiving a long-term PPI3,4.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.